Cargando…
The Vernakalant Story: How Did It Come to Approval in Europe and What is the Delay in the U.S.A?
The sudden onset of atrial fibrillation (AF) is often associated with rapid irregular palpitations, chest pain, shortness of breath and considerable anxiety. If a patient presents shortly after the onset of the arrhythmia the physician may adopt initially an expectant “wait and see” policy, perhaps...
Autor principal: | A, John Camm MD |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101194/ https://www.ncbi.nlm.nih.gov/pubmed/24821654 http://dx.doi.org/10.2174/1573403X10666140513103709 |
Ejemplares similares
-
U.S. - Mexican Relations (1910-1940): How Did The United States Come To Terms With The Mexican Revolution, And How Did The Revolution Come To Terms With The United States?
por: Galindo, José
Publicado: (2014) -
Introducing Vernakalant into Clinical Practice
por: Hall, Angela JM, et al.
Publicado: (2019) -
Duplicate publication—what’s going up must come down
por: Camm, Christian Fielder, et al.
Publicado: (2022) -
Are we at the Goal Line with the Novel Oral Anticoagulants and Have We Reached the End of the Line for Dronedarone and Vernakalant – or is There More to Come?
por: Reiffel, James A
Publicado: (2014) -
Vernakalant and electrical cardioversion for AF – Safe and effective
por: Simon, Alexander, et al.
Publicado: (2019)